Breaks Categories: Stock Spotlights

MondayAug 23, 2021 12:24 pm

CannabisNewsBreaks – Why Flora Growth Corp. (NASDAQ: FLGC) Is ‘One to Watch’

Flora Growth Corp. (NASDAQ: FLGC), an internationally focused cannabis brand builder, boasts a portfolio that spans several verticals, including pharmaceuticals, textiles, cosmetics, and food and beverage — each with a thoughtful brand designed to resonate with its intended end customer. From Flora Lab SAS and Flora Beauty to KASA Wholefoods and Hemp Textiles & Co., each of its brands prioritizes natural ingredients and value-chain sustainability, consistent with its mission. Though the company is currently organically growing market share for its existing brand portfolio, it is also seeking revenue-generating acquisitions that offer an accretive distribution network to amplify growth. As such,…

Continue Reading

FridayAug 20, 2021 1:21 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Announces Progress That Tells of the Dawn of Exciting Times

Red White & Bloom Brands’ (CSE: RWB) (OTCQX: RWBYF) CEO Brad Rogers, in a statement contained in the company’s investor deck presentation, observed that multiple deals, “judiciously purchased and diligently structured,” were coming together to create “the most exciting times in the history of the company.” Rogers further noted that the company was focused on building its key assets and growing the bottom line for its shareholders. “Red White & Bloom recently made two announcements that show its progress thus far and perhaps tell of the dawn of the exciting times. On July 22, the company announced its Q4 2020…

Continue Reading

ThursdayAug 19, 2021 12:56 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM), BayMedica Collaborate to Build Leading Rare Cannabinoid Company

InMed Pharmaceuticals (NASDAQ: INM) is a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates and manufacturing technologies for pharmaceutical-grade rare cannabinoids. The company is creating a pipeline of drug candidates to treat various diseases with high unmet medical needs. “In a move to grow its market presence and strengthen its operations, the company announced that it had entered into a non-binding letter of intent (“LOI”) to acquire BayMedica Inc.,” reads a recent article. “This announcement followed the two parties’ reciprocal research collaboration agreement back in November 2020, which saw them collaborate on several projects since. The agreement allowed BayMedica to assess…

Continue Reading

MondayAug 16, 2021 12:30 pm

CannabisNewsBreaks – Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) Taps into ‘High-Achieving, Goal-Focused, Innovative Mover and Shaker Expertise’

Chalice Brands (CSE: CHAL) (OTCQB: CHALF), a consumer-driven cannabis company in medicinal and recreational marijuana market segments, recently appointed retail veteran Ginger Mollo as chief integration officer for the company and general manager of Fifth & Root, a nationally recognized CBD skin-care brand based in California. “Mollo brings extensive experience with her; she has held several positions in retail and company development at companies such as Limited Brands and Apple,” reads a recent article. Chalice CEO and president Jeff Yapp, while speaking about the appointment, said, “We are thrilled to add Ginger, the woman who had her fingertips on Apple…

Continue Reading

FridayAug 13, 2021 2:51 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH Provides Potential for Significant Cost Savings to Health Care System

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently announced the results of its antiviral drug molecular characterization study performed by the National Research Council (“NRC”). The results confirmed that the drugs tested remained stable and did not undergo changes in chemical structure when processed with DehydraTECH. “This could preserve the ability of this drug delivery platform to qualify for accelerated regulatory filings with the Food and Drug Administration (‘FDA’) in the United States plus regulators elsewhere in the world,” reads a recent article. “The potential for more rapid market authorization of DehydraTECH provides the potential for cost savings to the health care…

Continue Reading

FridayAug 13, 2021 2:35 pm

CannabisNewsBreaks – RYAH Group Inc.’s (CSE: RYAH) State-of-the-Art IoT Products Provide Holistic View for Optimal Research

RYAH Group (CSE: RYAH), a connected device and big data and technology company, is standing by to provide a wealth of smart devices, artificial intelligence and an integrated platform that will fully support the U.S. as it explores the benefits, risks and effects of cannabis. “U.S. researchers can benefit from RYAH Group’s state-of-the-art IoT suite of products. The technology collects, analyzes and leverages objective data throughout the research process. As a result, the company boasts one of the largest plant-based medicine databases globally with 200,000 plus registered users. The company’s ecosystem of products allows data to be collected from seed…

Continue Reading

FridayAug 06, 2021 2:01 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Well Positioned to Advance Business, Further Execute on Drug-Delivery Goals

Lexaria Bioscience Corp. (NASDAQ: LEXX) is constantly collaborating with research institutions and businesses to identify new ways to innovate and improve its DehydraTECH(TM) drug-delivery technology. DehydraTECH is already being monetized through commercial use, and the company is utilizing advanced 2.0 formulations in ongoing human studies. A recent article discusses Lexaria’s move to consolidate the trading of its shares solely on the Nasdaq, and resulting advantages to the company and its shareholders. “Since it was listed back in January 2021, a substantial fraction of its shareholders moved onto this exchange. To them, it offered more liquidity than ever before, and to…

Continue Reading

FridayAug 06, 2021 1:45 pm

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Paving Way for Better Outcomes of Plant-Based Treatments

RYAH Group (CSE: RYAH), a connected device and big data and technology company, is known for its high-quality information and digital health care analytics through which it is positively impacting the future treatment of patients for various medical conditions worldwide. RYAH is partnering with the University of Milan and companies like Medical Kiwi to drive innovation and deliver cutting-edge medical solutions, as well as providing the necessary dose-measuring devices to an oncology clinic in the U.K. “RYAH Group is paving the way for a better understanding and better outcomes of plant-based treatments globally,” reads a recent article. “This is achieved…

Continue Reading

ThursdayAug 05, 2021 12:32 pm

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Boasts Unique, Diverse Portfolio of Natural Health Products

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, early this year completed the acquisition of Naturo Group, marking its expansion in the U.S. infused functional beverage market. The acquisition created an ideal situation for BevCanna to compete more effectively in the traditional functional beverage category. BevCanna is a leader in the cannabis-infused beverage and nutraceutical industry, while Naturo Group’s innovative plant-based mineral beverage and supplement brand, TRACE, and significant manufacturing infrastructure and international distribution networks, form the foundation of an industry-leading health and wellness company. “With the acquisition completed in…

Continue Reading

FridayJul 30, 2021 12:13 pm

CannabisNewsBreaks – Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) Leveraging Perfect Fit in Oregon Footprint Expansion

Chalice Brands (CSE: CHAL) (OTCQB: CHALF), a consumer-driven cannabis company in medicinal and recreational marijuana market segments, recently announced the acquisition of Homegrown dispensaries, which brought a chain of five Oregon-based retail dispensaries under its umbrella. The acquisition, which comes as business is booming for cannabis companies, expands Chalice’s retail stores from 7 to 12 locations in the state of Oregon. “We have been diligently searching for the appropriate footprint expansion for our retail business in Oregon that represented the right fit and to be in a position to fund the acquisition,” Chalice Brands president and CEO Jeff Yapp was…

Continue Reading